Proyecto PESA - Progression of early subclinical atherosclerosis

MICINN, ISCIII, CNIC, Fundación PROCNIC, Santander MICINN ISCIII CNIC Fundación PROCNIC Santander Proyecto PESA - Progression of early subclinical atherosclerosis

Publicaciones

  1. Fernandez-Ortiz A, Jimenez-Borreguero LJ, Penalvo JL, Ordovas JM, Mocoroa A, Fernandez-Friera L, Laclaustra M, Garcia L, Molina J, Mendiguren JM, Lopez-Melgar B, de Vega VM, Alonso-Farto JC, Guallar E, Sillesen H, Rudd JH, Fayad ZA, Ibanez B, Sanz G, Fuster V. The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: Rationale and design. Am Heart J. 2013;166(6):990-8. doi: 10.1016/j.ahj.2013.08.024. PMID: 24268213.
  2. Fernández-Friera L, Ibáñez B, Fuster V. Imaging subclinical atherosclerosis: is it ready for prime time? A review. J Cardiovasc Transl Res. 2014; 7(7):623-34. doi: 10.1007/s12265-014-9582-4. PMID: 25119855.
  3. Fernandez-Friera L, Penalvo JL, Fernandez-Ortiz A, Ibanez B, Lopez-Melgar B, Laclaustra M, Oliva B, Mocoroa A, Mendiguren J, Martinez de Vega V, Garcia L, Molina J, Sanchez-Gonzalez J, Guzman G, Alonso-Farto JC, Guallar E, Civeira F, Sillesen H, Pocock S, Ordovas JM, Sanz G, Jimenez-Borreguero LJ, Fuster V. Prevalence, Vascular Distribution and Multi-territorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation. 2015;131(24):2104-13. doi: 10.1161/CIRCULATIONAHA.114.014310. PMID: 25882487.
    http://hdl.handle.net/20.500.12105/8352
  4. Fernandez-Alvira JM, Fuster V, Dorado B, Soberon N, Flores I, Gallardo M, Pocock S, Blasco MA, Andres V. Short Telomere Load, Telomere Length, and Subclinical Atherosclerosis: The PESA Study. J Am Coll Cardiol. 2016;67(21):2467-76. doi: 10.1016/j.jacc.2016.03.530. PMID: 27230041.
    http://hdl.handle.net/20.500.12105/5229
  5. Penalvo JL, Fernandez-Friera L, Lopez-Melgar B, Uzhova I, Oliva B, Fernandez-Alvira JM, Laclaustra M, Pocock S, Mocoroa A, Mendiguren JM, Sanz G, Guallar E, Bansilal S, Vedanthan R, Jimenez-Borreguero LJ, Ibanez B, Ordovas JM, Fernandez-Ortiz A, Bueno H, Fuster V. Association Between a Social-Business Eating Pattern and Early Asymptomatic Atherosclerosis. J Am Coll Cardiol. 2016;68(8):805-14. doi: 10.1016/j.jacc.2016.05.080. PMID: 27539172.
    http://hdl.handle.net/20.500.12105/5204
  6. López-Melgar B, Fernández-Friera L, Sánchez-González J, Vilchez JP, Cecconi A, Mateo J, Peñalvo JL, Oliva B, García-Ruiz JM, Kauffman S, Jiménez-Borreguero LJ, Ruiz-Cabello J, Fernández-Ortiz A, Ibáñez B, Fuster V. Accurate quantification of atherosclerotic plaque volume by 3D vascular ultrasound using the volumetric linear array method. Atherosclerosis. 2016; 248:230-7. doi: 10.1016/j.atherosclerosis.2016.03.002. PMID: 27038420.
    http://hdl.handle.net/20.500.12105/11871
  7. Hurtado-Roca Y, Bueno H, Fernandez-Ortiz A, Ordovas JM, Ibanez B, Fuster V, Rodriguez-Artalejo F, Laclaustra M. Oxidized LDL is Associated with Metabolic Syndrome Traits Independently of Central Obesity and Insulin Resistance. Diabetes. 2017;66(2):474-82. doi: 10.2337/db16-0933. PMID: 27993926.
    http://hdl.handle.net/20.500.12105/8355
  8. Coffeng JK, van der Ploeg HP, Castellano JM, Fernandez-Alvira JM, Ibanez B, Garcia-Lunar I, van der Beek AJ, Fernandez-Ortiz A, Mocoroa A, Garcia-Leal L, Cardenas E, Rojas C, Martinez-Castro MI, Santiago-Sacristan S, Fernandez-Gallardo M, Mendiguren JM, Bansilal S, van Mechelen W, Fuster V. A 30-month worksite-based lifestyle program to promote cardiovascular health in middle-aged bank employees: Design of the TANSNIP-PESA randomized controlled trial. Am Heart J. 2017;184:121-32. doi: 10.1016/j.ahj.2016.11.002. PMID: 28224926.
    http://hdl.handle.net/20.500.12105/5164
  9. Lopez-Melgar B, Fernandez-Friera L, Oliva B, Garcia-Ruiz JM, Penalvo JL, Gomez-Talavera S, Sanchez-Gonzalez J, Mendiguren JM, Ibanez B, Fernandez-Ortiz A, Sanz J, Fuster V. Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study. J Am Coll Cardiol. 2017;70(3):301-13. doi: 10.1016/j.jacc.2017.05.033. PMID: 28705310.
    http://hdl.handle.net/20.500.12105/8353
  10. Uzhova I, Fuster V, Fernandez-Ortiz A, Ordovas JM, Sanz J, Fernandez-Friera L, Lopez-Melgar B, Mendiguren JM, Ibanez B, Bueno H, Penalvo JL. The Importance of Breakfast in Atherosclerosis Disease: Insights From the PESA Study. J Am Coll Cardiol. 2017;70(15):1833-42. doi: 10.1016/j.jacc.2017.08.027. PMID: 28982495.
    https://www.sciencedirect.com/science/article/pii/S0735109717393178?via%3Dihub
  11. Fernandez-Alvira JM, Fuster V, Pocock S, Sanz J, Fernandez-Friera L, Laclaustra M, Fernandez-Jimenez R, Mendiguren J, Fernandez-Ortiz A, Ibanez B, Bueno H. Predicting Subclinical Atherosclerosis in Low-Risk Individuals: Ideal Cardiovascular Health Score and Fuster-BEWAT Score. J Am Coll Cardiol. 2017;70(20):2463-73. doi: 10.1016/j.jacc.2017.09.032. PMID: 29145946.
    http://hdl.handle.net/20.500.12105/6493
  12. Fernandez-Friera L, Fuster V, Lopez-Melgar B, Oliva B, Garcia-Ruiz JM, Mendiguren J, Bueno H, Pocock S, Ibanez B, Fernandez-Ortiz A, Sanz J. Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors. J Am Coll Cardiol. 2017;70(24):2979-91. doi: 10.1016/j.jacc.2017.10.024. PMID: 29241485.
    http://hdl.handle.net/20.500.12105/7211
  13. Dominguez F, Fuster V, Fernandez-Alvira JM, Fernandez-Friera L, Lopez-Melgar B, Blanco-Rojo R, Fernandez-Ortiz A, Garcia-Pavia P, Sanz J, Mendiguren JM, Ibanez B, Bueno H, Lara-Pezzi E, Ordovas JM. Association of Sleep Duration and Quality With Subclinical Atherosclerosis. J Am Coll Cardiol. 2019;73(2):134-44. doi: 10.1016/j.jacc.2018.10.060. PMID: 30654884.
    http://hdl.handle.net/20.500.12105/7988
  14. Tsilingiri K, de la Fuente H, Relano M, Sanchez-Diaz R, Rodriguez C, Crespo J, Sanchez-Cabo F, Dopazo A, Alonso-Lebrero JL, Vara A, Vazquez J, Casasnovas JM, Alfonso F, Ibanez B, Fuster V, Martinez-Gonzalez J, Martin P, Sanchez-Madrid F. oxLDL Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease. Circulation. 2019;139(2):243-55. doi: 10.1161/circulationaha.118.034326. PMID: 30586697.
    http://hdl.handle.net/20.500.12105/7016
  15. Fernandez-Friera L, Fuster V, Lopez-Melgar B, Oliva B, Sanchez-Gonzalez J, Macias A, Perez-Asenjo B, Zamudio D, Alonso-Farto JC, Espana S, Mendiguren J, Bueno H, Garcia-Ruiz JM, Ibanez B, Fernandez-Ortiz A, Sanz J. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI. J Am Coll Cardiol. 2019;73(12):1371-82. doi: 10.1016/j.jacc.2018.12.075. PMID: 30922468.
    http://hdl.handle.net/20.500.12105/8351
  16. Redondo-Bravo L, Fernandez-Alvira JM, Gorriz J, Mendiguren JM, Sanz J, Fernandez-Friera L, Garcia-Ruiz JM, Fernandez-Ortiz A, Ibanez B, Bueno H, Fuster V. Does Socioeconomic Status Influence the Risk of Subclinical Atherosclerosis?: A Mediation Model. J Am Coll Cardiol. 2019;74(4):526-35. doi: 10.1016/j.jacc.2019.05.042. PMID: 31345427.
    http://hdl.handle.net/20.500.12105/8348
  17. Yin X, Willinger CM, Keefe J, Liu J, Fernández-Ortiz A, Ibáñez B, Peñalvo J, Adourian A, Chen G, Corella D, Pamplona R, Portero-Otin M, Jove M, Courchesne P, van Duijn CM, Fuster V, Ordovás JM, Demirkan A, Larson MG, Levy D. Lipidomic profiling identifies signatures of metabolic risk. 2020; 51: 102520. doi: 10.1016/j.ebiom.2019.10.046. PMID: 31877415.
    http://hdl.handle.net/20.500.12105/9287
  18. de la Chica JA, Gómez-Talavera S, García-Ruiz JM, García-Lunar I, Oliva B, Fernández-Alvira JM, López-Melgar B, Sánchez-González J, de la Pompa JL, Mendiguren JM, Martínez de Vega V, Fernández-Ortiz A, Sanz J, Fernández-Friera L, Ibáñez B, Fuster V. Association Between Left Ventricular Noncompaction and Vigorous Physical Activity. J Am Coll Cardiol. 2020; 76(15):1723-1733. doi: 10.1016/j.jacc.2020.08.030. PMID: 33032733.
    http://hdl.handle.net/20.500.12105/11778
  19. Sánchez-Cabo F, Rossello X, Fuster V, Benito F, Manzano JP, Silla JC, Fernández-Alvira JM, Oliva B, Fernández-Friera L, López-Melgar B, Mendiguren JM, Sanz J, Ordovás JM, Andrés V, Fernández-Ortiz A, Bueno H, Ibáñez B, García-Ruiz JM, Lara-Pezzi E. Machine Learning Improves Cardiovascular Risk Definition for Young, Asymptomatic Individuals. J Am Coll Cardiol. 2020; 76(14): 1674-1685. doi: 10.1016/j.jacc.2020.08.017. PMID: 33004133.
    http://hdl.handle.net/20.500.12105/11236
  20. Rossello X, Fuster V, Oliva B, Sanz J, Fernández Friera LA, López-Melgar B, Mendiguren JM, Lara-Pezzi E, Bueno H, Fernández-Ortiz A, Ibanez B, Ordovás JM. Association Between Body Size Phenotypes and Subclinical Atherosclerosis. J Clin Endocrinol Metab. 2020; 105(12):3734-44. doi: 10.1210/clinem/dgaa620. PMID: 32879953.
    http://hdl.handle.net/20.500.12105/11189
  21. Martínez-López D, Roldan-Montero R, García-Marqués F, Nuñez E, Jorge I, Camafeita E, Minguez P, Rodriguez de Cordoba S, López-Melgar B, Lara-Pezzi E, Fernández-Ortiz A, Ibáñez B, Valdivielso JM, Fuster V, Michel JB, Blanco-Colio LM, Vázquez J, Martin-Ventura JL. Complement C5 Protein as a Marker of Subclinical Atherosclerosis. J Am Coll Cardiol. 2020; 75(16):1926-1941. doi: 10.1016/j.jacc.2020.02.058. PMID: 32327104.
    http://hdl.handle.net/20.500.12105/10326
  22. López-Melgar B, Fernández-Friera L, Oliva B, García-Ruiz JM, Sánchez-Cabo F, Bueno H, Mendiguren JM, Lara-Pezzi E, Andrés V, Ibáñez B, Fernández-Ortiz A, Sanz J, Fuster V. Short-Term Progression of Multiterritorial Subclinical Atherosclerosis. J Am Coll Cardiol. 2020; 75(14):1617-1627. doi: 10.1016/j.jacc.2020.02.026. PMID: 32273027.
    http://hdl.handle.net/20.500.12105/10331
  23. Cortes-Canteli M, Gispert JD, Salvadó G, Toribio-Fernandez R, Tristao-Pereira C, Falcon C, Oliva B, Mendiguren J, Fernandez-Friera L, Sanz J, Garcia-Ruiz JM, Fernandez-Ortiz A, Sanchez-Gonzalez J, Ibanez B, Molinuevo JL, Fuster V. Subclinical atherosclerosis and brain metabolism in midlife. The PESA study. J Am Coll Cardiol. [To be published in February 2021]
2014 © PESA CNIC-Santander. Todos los derechos reservados.